QT
LYEL icon

Quantamental Technologies’s Lyell Immunopharma LYEL Stock Holding History

Quantamental Technologies’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-646
Closed -$95K – 573
2022
Q3 		$95K Buy
+646
New +$87.5K 0.04% 452

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantamental Technologies's LYEL Position: Q4 2022 in Review

Quantamental Technologies sold out of Lyell Immunopharma (LYEL) in Q4 2022, closing a stake of 646 shares — an estimated $95K sold.

Quantamental Technologies first reported a position in LYEL in Q3 2022 and held it in 1 quarter. The position peaked at $95K in Q3 2022. 93 funds tracked by Wall St. Rank hold LYEL as of Q4 2022.

  • Quantamental Technologies reported no remaining Lyell Immunopharma position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 646 Lyell Immunopharma shares in Q4 2022, an estimated $95K.
  • Quantamental Technologies first reported a position in Lyell Immunopharma in Q3 2022 and held it in 1 quarter.
  • Quantamental Technologies's Lyell Immunopharma position peaked at $95K in Q3 2022.
  • 93 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.